CryoLife, Inc. (CryoLife,) is a biological medical device company. The Company preserves and distributes human tissues for transplantation and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve (CryoValve SGPV) and the CryoPatch SG pulmonary cardiac patch tissue (CryoPatch SG), both processed using CryoLife�s SynerGraft technology. The Company operates in two segments: preservation services and medical devices segment. In May 2011, it acquired Cardiogenesis Corporation. In February 2014, CryoLife Inc announced the establishment of CryoLife Asia Pacific Pte. Ltd.